Search Count: 27
 |
Crystal Structure Of Hiv-1 Reverse Transcriptase In Complex With (E)-4-(3-Chloro-5-(2-Cyanovinyl)Phenoxy)-3-(2-(2,4-Dioxo-3,4-Dihydropyrimidin-1(2H)-Yl)Ethoxy)Phenyl Sulfurofluoridate (Jlj709)
Organism: Human immunodeficiency virus type 1 group m subtype b
Method: X-RAY DIFFRACTION Resolution:2.65 Å Release Date: 2021-01-13 Classification: TRANSFERASE, Hydrolase/Inhibitor Ligands: X2J |
Organism: Human immunodeficiency virus type 1 group m subtype b
Method: X-RAY DIFFRACTION
Release Date: 2021-01-13
Ligands: X2J
 |
Crystal Structure Of Hiv-1 Reverse Transcriptase In Complex With 4-(3-Chloro-5-Cyanophenoxy)-3-(2-(2,4-Dioxo-3,4-Dihydropyrimidin-1(2H)-Yl)Ethoxy)Phenyl Sulfurofluoridate (Jlj702)
Organism: Human immunodeficiency virus type 1 group m subtype b
Method: X-RAY DIFFRACTION Resolution:2.70 Å Release Date: 2021-01-13 Classification: TRANSFERASE, Hydrolase/Inhibitor Ligands: X2S |
Organism: Human immunodeficiency virus type 1 group m subtype b
Method: X-RAY DIFFRACTION
Release Date: 2021-01-13
Ligands: X2S
 |
Crystal Structure Of Hiv-1 Reverse Transcriptase In Complex With 4-((6-Cyanonaphthalen-1-Yl)Oxy)-3-(2-(2,4-Dioxo-3,4-Dihydropyrimidin-1(2H)-Yl)Ethoxy)Phenyl Sulfurofluoridate (Jlj704)
Organism: Human immunodeficiency virus type 1 group m subtype b
Method: X-RAY DIFFRACTION Resolution:2.73 Å Release Date: 2021-01-13 Classification: TRANSFERASE, Hydrolase/Inhibitor Ligands: X2V |
Organism: Human immunodeficiency virus type 1 group m subtype b
Method: X-RAY DIFFRACTION
Release Date: 2021-01-13
Ligands: X2V
 |
Crystal Structure Of Hiv-1 Reverse Transcriptase In Complex With (E)-4-(3-(2-Cyanovinyl)-5-Fluorophenoxy)-3-(2-(2,4-Dioxo-3,4-Dihydropyrimidin-1(2H)-Yl)Ethoxy)Phenyl Sulfurofluoridate (Jlj710)
Organism: Human immunodeficiency virus type 1 group m subtype b
Method: X-RAY DIFFRACTION Resolution:2.60 Å Release Date: 2021-01-13 Classification: TRANSFERASE, Hydrolase/Inhibitor Ligands: X2G |
Organism: Human immunodeficiency virus type 1 group m subtype b
Method: X-RAY DIFFRACTION
Release Date: 2021-01-13
Ligands: X2G
 |
Crystal Structure Of Ts-Dhfr From Cryptosporidium Hominis In Complex With Nadph, Fdump And 2-(4-((2-Amino-4-Oxo-4,7-Dihydro-3H-Pyrrolo[2,3-D]Pyrimidin-5-Yl)Methyl)Benzamido)Terephthalic Acid
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.50 Å Release Date: 2019-10-16 Classification: TRANSFERASE/TRANSFERASE INHIBITOR Ligands: UMP, OEJ |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2019-10-16
Ligands: UMP, OEJ
 |
Crystal Structure Of Ts-Dhfr From Cryptosporidium Hominis In Complex With Nadph, Fdump And 2-(2-(4-((2-Amino-4-Oxo-4,7-Dihydro-3H-Pyrrolo[2,3-D]Pyrimidin-5-Yl)Methyl)Benzamido)-4-Methoxyphenyl)Acetic Acid
Organism: Cryptosporidium hominis
Method: X-RAY DIFFRACTION Resolution:2.69 Å Release Date: 2019-10-16 Classification: TRANSFERASE/TRANSFERASE INHIBITOR Ligands: NDP, UFP, OED, MTX |
Organism: Cryptosporidium hominis
Method: X-RAY DIFFRACTION
Release Date: 2019-10-16
Ligands: NDP, UFP, OED, MTX
 |
Crystal Structure Of Human Thymidylate Synthase Delta (7-29) In Complex With Dump And 2-(4-((2-Amino-4-Oxo-4,7-Dihydro-3H-Pyrrolo[2,3-D]Pyrimidin-5-Yl)Methyl)Benzamido)-4-Chlorobenzoic Acid
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.39 Å Release Date: 2019-10-02 Classification: transferase/transferase inhibitor Ligands: UMP, OE7 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2019-10-02
Ligands: UMP, OE7
 |
Crystal Structure Of Human Thymidylate Synthase Delta (7-29) In Complex With Dump And 2-(2-(4-((2-Amino-4-Oxo-4,7-Dihydro-3H-Pyrrolo[2,3-D]Pyrimidin-5-Yl)Methyl)Benzamido)Phenyl)Acetic Acid
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.85 Å Release Date: 2019-10-02 Classification: transferase/transferase inhibitor Ligands: UMP, OF7 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2019-10-02
Ligands: UMP, OF7
 |
Crystal Structure Of Human Thymidylate Synthase Delta (7-29) In Complex With Dump And 2-(2-(4-((2-Amino-4-Oxo-4,7-Dihydro-3H-Pyrrolo[2,3-D]Pyrimidin-5-Yl)Methyl)Benzamido)-4-Methoxyphenyl)Acetic Acid
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.39 Å Release Date: 2019-10-02 Classification: transferase/transferase inhibitor Ligands: UMP, OED |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2019-10-02
Ligands: UMP, OED
 |
Crystal Structure Of Ts-Dhfr From Cryptosporidium Hominis In Complex With Nadph, Fdump And 2-(4-((2-Amino-4-Oxo-4,7-Dihydro-3H-Pyrrolo[2,3-D]Pyrimidin-5-Yl)Methyl)Benzamido)Benzoic Acid
Organism: Cryptosporidium hominis
Method: X-RAY DIFFRACTION Resolution:2.80 Å Release Date: 2019-10-02 Classification: TRANSFERASE/TRANSFERASE INHIBITOR Ligands: NDP, UFP, OG7, MTX, SO4 |
Organism: Cryptosporidium hominis
Method: X-RAY DIFFRACTION
Release Date: 2019-10-02
Ligands: NDP, UFP, OG7, MTX, SO4
 |
Crystal Structure Of Ts-Dhfr From Cryptosporidium Hominis In Complex With Nadph, Fdump And 2-(4-((2-Amino-4-Oxo-4,7-Dihydro-3H-Pyrrolo[2,3-D]Pyrimidin-5-Yl)Methyl)Benzamido)-4-Chlorobenzoic Acid
Organism: Cryptosporidium hominis
Method: X-RAY DIFFRACTION Resolution:2.53 Å Release Date: 2019-10-02 Classification: TRANSFERASE/TRANSFERASE INHIBITOR Ligands: NDP, UFP, OE7, MTX |
Organism: Cryptosporidium hominis
Method: X-RAY DIFFRACTION
Release Date: 2019-10-02
Ligands: NDP, UFP, OE7, MTX
 |
Crystal Structure Of Ts-Dhfr From Cryptosporidium Hominis In Complex With Nadph, Fdump And 2-(2-(4-((2-Amino-4-Oxo-4,7-Dihydro-3H-Pyrrolo[2,3-D]Pyrimidin-5-Yl)Methyl)Benzamido)Phenyl)Acetic Acid.
Organism: Cryptosporidium hominis
Method: X-RAY DIFFRACTION Resolution:2.89 Å Release Date: 2019-10-02 Classification: TRANSFERASE/TRANSFERASE INHIBITOR Ligands: NDP, UFP, OF7, MTX, SO4 |
Organism: Cryptosporidium hominis
Method: X-RAY DIFFRACTION
Release Date: 2019-10-02
Ligands: NDP, UFP, OF7, MTX, SO4
 |
Crystal Structure Of Ts-Dhfr From Cryptosporidium Hominis In Complex With Nadph, Fdump And 2-((4-((2-Amino-4-Oxo-4,7-Dihydro-3H-Pyrrolo[2,3-D]Pyrimidin-5-Yl)Methyl)Benzamido)Methyl)Benzoic Acid.
Organism: Cryptosporidium hominis
Method: X-RAY DIFFRACTION Resolution:2.79 Å Release Date: 2019-10-02 Classification: TRANSFERASE/TRANSFERASE INHIBITOR Ligands: NDP, UFP, OF4, MTX, SO4 |
Organism: Cryptosporidium hominis
Method: X-RAY DIFFRACTION
Release Date: 2019-10-02
Ligands: NDP, UFP, OF4, MTX, SO4
 |
Crystal Structure Of Ts-Dhfr From Cryptosporidium Hominis In Complex With Nadph, Fdump And 3-(2-(4-((2-Amino-4-Oxo-4,7-Dihydro-3H-Pyrrolo[2,3-D]Pyrimidin-5-Yl)Methyl)Benzamido)Phenyl)Propanoic Acid.
Organism: Cryptosporidium hominis
Method: X-RAY DIFFRACTION Resolution:3.09 Å Release Date: 2019-10-02 Classification: TRANSFERASE/TRANSFERASE INHIBITOR Ligands: NDP, UFP, OG4, MTX |
Organism: Cryptosporidium hominis
Method: X-RAY DIFFRACTION
Release Date: 2019-10-02
Ligands: NDP, UFP, OG4, MTX
 |
Crystal Structure Of Ts-Dhfr From Cryptosporidium Hominis In Complex With Nadph, Fdump And 2-(4-((2-Amino-4-Oxo-4,7-Dihydro-3H-Pyrrolo[2,3-D]Pyrimidin-5-Yl)Methyl)Benzamido)Terephthalic Acid.
Organism: Cryptosporidium hominis
Method: X-RAY DIFFRACTION Resolution:3.32 Å Release Date: 2019-10-02 Classification: transferase/transferase inhibitor Ligands: NDP, UFP, OEJ, MTX |
Organism: Cryptosporidium hominis
Method: X-RAY DIFFRACTION
Release Date: 2019-10-02
Ligands: NDP, UFP, OEJ, MTX
 |
Crystal Structure Of Ts-Dhfr From Cryptosporidium Hominis In Complex With Nadph, Fdump And 2-(4-((2-Amino-4-Oxo-4,7-Dihydro-3H-Pyrrolo[2,3-D]Pyrimidin-5-Yl)Methyl)Benzamido)-4-Methoxybenzoic Acid.
Organism: Cryptosporidium hominis
Method: X-RAY DIFFRACTION Resolution:2.81 Å Release Date: 2019-10-02 Classification: transferase/transferase inhibitor Ligands: NDP, UFP, OEA, MTX |
Organism: Cryptosporidium hominis
Method: X-RAY DIFFRACTION
Release Date: 2019-10-02
Ligands: NDP, UFP, OEA, MTX
 |
Crystal Structure Of Ts-Dhfr From Cryptosporidium Hominis In Complex With Nadph, Fdump And 2-(4-((2-Amino-4-Oxo-4,7-Dihydro-3H-Pyrrolo[2,3-D]Pyrimidin-5-Yl)Methyl)Benzamido)-4-Cyanobenzoic Acid.
Organism: Cryptosporidium hominis
Method: X-RAY DIFFRACTION Resolution:2.98 Å Release Date: 2019-10-02 Classification: transferase/transferase inhibitor Ligands: NDP, UFP, OG1, MTX, SO4 |
Organism: Cryptosporidium hominis
Method: X-RAY DIFFRACTION
Release Date: 2019-10-02
Ligands: NDP, UFP, OG1, MTX, SO4
 |
Crystal Structure Of Ts-Dhfr From Cryptosporidium Hominis In Complex With Nadph, Fdump And 2-(4-((2-Amino-4-Oxo-4,7-Dihydro-3H-Pyrrolo[2,3-D]Pyrimidin-5-Yl)Methyl)Benzamido)-4-Carbamoylbenzoic Acid.
Organism: Cryptosporidium hominis
Method: X-RAY DIFFRACTION Resolution:2.71 Å Release Date: 2019-10-02 Classification: transferase/transferase inhbitor Ligands: NDP, UFP, OFJ, MTX, SO4 |
Organism: Cryptosporidium hominis
Method: X-RAY DIFFRACTION
Release Date: 2019-10-02
Ligands: NDP, UFP, OFJ, MTX, SO4
 |
Crystal Structure Of Ts-Dhfr From Cryptosporidium Hominis In Complex With Nadph, Fdump And 2-(2-(4-((2-Amino-4-Oxo-4,7-Dihydro-3H-Pyrrolo[2,3-D]Pyrimidin-5-Yl)Methyl)Benzamido)-4-Cyanophenyl)Acetic Acid.
Organism: Cryptosporidium hominis
Method: X-RAY DIFFRACTION Resolution:2.94 Å Release Date: 2019-10-02 Classification: transferase/transferase inhibitor Ligands: NDP, UFP, OFD, MTX |
Organism: Cryptosporidium hominis
Method: X-RAY DIFFRACTION
Release Date: 2019-10-02
Ligands: NDP, UFP, OFD, MTX
 |
Crystal Structure Of Ts-Dhfr From Cryptosporidium Hominis In Complex With Nadph, Fdump And 3-(4-((2-Amino-4-Oxo-4,7-Dihydro-3H-Pyrrolo[2,3-D]Pyrimidin-5-Yl)Methyl)Benzamido)-4-(Carboxymethyl)Benzoic Acid.
Organism: Cryptosporidium hominis
Method: X-RAY DIFFRACTION Resolution:2.89 Å Release Date: 2019-10-02 Classification: transferase/transferase inhibitor Ligands: NDP, UFP, OEP, MTX |
Organism: Cryptosporidium hominis
Method: X-RAY DIFFRACTION
Release Date: 2019-10-02
Ligands: NDP, UFP, OEP, MTX